UPS is spending $48 million to keep up with the GLP-1 boom. The drugs that need refrigeration are reshaping logistics

UPS is investing $48 million to build 27 temperature-controlled facilities across three continents to meet the rising demand for refrigerated pharmaceuticals driven by the GLP-1 drug boom. The expansion reflects growing logistical challenges for shipping refrigerated medications.